Partner Interview
Published February 3, 2025
Dr Lal Pathlabs: Competitor Perspective
inpractise.com/articles/dr-lal-pathlabs-competitor-perspective
Executive Bio
Regional Sales Manager at Apollo Diagnostics
Interview Transcript
Disclaimer: This interview is for informational purposes only and should not be relied upon as a basis for investment decisions. In Practise is an independent publisher and all opinions expressed by guests are solely their own opinions and do not reflect the opinion of In Practise.
This is a snippet of the transcript.to get full access.
Yes, that's what I want. At SRL and at Apollo, what are your major responsibilities?
In this B2B business, we are dealing with significant price competition. For example, if the XYZ center is not performing the thyroid stimulating hormone (TSH) test because they lack the machine, they outsource it to a nationalized lab. This leads to rate competition as they look for the cheapest outsourcing option.
This is a snippet of the transcript.to get full access.
Yes, that's what I want. At SRL and at Apollo, what are your major responsibilities?
They might contact Dr. Lal PathLabs, offering to send 100 TSH samples a month and ask for the per-test cost. If Dr. Lal offers them a price of 60 or 100 rupees per TSH test, they will then compare this with Metropolis or SRL's prices. This is a practical scenario currently happening in India.
This is a snippet of the transcript.to get full access.
And the other organizations are primarily what, just mom-and-pop shops?
Yes, exactly. There are national leaders like Dr. Lal, SRL, Apollo, Metropolis, etc. These organized players are making only 5,000 crore per annum. The market opportunity is around 85,000 crore, which is a B2B opportunity.
Free Sample of 50+ Interviews
Sign up to test our content quality with a free sample of 50+ interviews.
Or contact sales for full access
Related Content
© 2024 In Practise. All rights reserved. This material is for informational purposes only and should not be considered as investment advice.
